(Q46609201)

English

The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats.

scientific article published on 15 January 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

0 references

Ernesto Martinez-Martinez

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Victoria Cachofeiro

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Cristina Rodríguez

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Raquel Jurado-López

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

José Martínez-González

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

María Miana

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

María Visitación Bartolomé

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

María Luaces

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Fabián Islas

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Natalia López-Andrés

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

15 January 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

92

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

96-104

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Midlife body mass index and hospitalization and mortality in older age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Cardiac remodeling and failure From molecules to man (Part II).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

A look between the cardiomyocytes: the extracellular matrix in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Arterial Stiffness as an Imaging Biomarker

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Mechanisms of hypertension in the cardiometabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Lysyl oxidase as a potential therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Low density lipoproteins downregulate lysyl oxidase in vascular endothelial cells and the arterial wall.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Intracellular lysyl oxidase: effect of a specific inhibitor on nuclear mass in proliferating cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Lysyl oxidase expression and collagen cross-linking during chronic adriamycin nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Lysyl oxidase deficiency: a new cause of human arterial dissection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Paradoxical roles for lysyl oxidases in cancer--a prospect

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

The potential role of leptin in the vascular remodeling associated with obesity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Comparative sensitivities of purified preparations of lysyl oxidase and other amine oxidases to active site-directed enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Features of cardiac remodeling, associated with blood pressure and fibrosis biomarkers, are frequent in subjects with abdominal obesity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Lysyl oxidase (LOX) in vascular remodelling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Myocardial lysyl oxidase regulation of cardiac remodeling in a murine model of diet-induced metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Left and right ventricle late remodeling following myocardial infarction in rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Collagen cross-linking but not collagen amount associates with elevated filling pressures in hypertensive patients with stage C heart failure: potential role of lysyl oxidase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Lysyl oxidase is required for vascular and diaphragmatic development in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Matrix crosslinking forces tumor progression by enhancing integrin signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

TNF-α increases cardiac fibroblast lysyl oxidase expression through TGF-β and PI3Kinase signaling pathways.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Cardiac fibrosis and vascular remodeling are attenuated by metformin in obese rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Exercise improves cardiac function and attenuates insulin resistance in Dahl salt-sensitive rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.01.012

7 January 2021

Identifiers

10.1016/J.YJMCC.2016.01.012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780438%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46609201&oldid=1370976261"